Publications: Dr Patricia McGettigan

Malik ME, Koeber L, Garred CH, Zahir D, Jensen J, Jensen MH, Holt A, Andersson C et al. ( 2024 ) . Hyponatremia and risk of new-onset heart failure in patients with type 2 diabetes - a real-world study of 70,000 patients . European Heart Journal vol. 45 , ( Supplement_1 )

Nielsen S, Holt AH, Lamberts ML, Nouhravesh NN, Jensen MHJ, Schjerning AMS, Malik MEM, Andersen JTA et al. ( 2024 ) . Pregnancy protection in women of child-bearing age prescribed ACE inhibitors, ARBs or statins - A nationwide cohort study . European Heart Journal vol. 45 , ( Supplement_1 )

de Abreu Nunes L, Hooper R, McGettigan P, Phillips R ( 2024 ) . Statistical methods leveraging the hierarchical structure of adverse events for signal detection in clinical trials: a scoping review of the methodological literature . BMC Medical Research Methodology vol. 24 , ( 1 )

Bogowicz P, Mehta A, Choudhary S, Brhlikova P, Roderick P, McGettigan P, Farooqui HH, Sharma AN et al. ( 2024 ) . Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study . Journal of Pharmaceutical Policy and Practice vol. 17 , ( 1 )

Holt A, McGettigan P, Lamberts M ( 2024 ) . Unmeasured confounding is always unnerving: cannabis and cardiovascular risk . European Heart Journal vol. 45 , ( 28 ) 2574 - 2575 .

Nielsen SK, Lamberts M, Nouhravesh N, Jensen MH, Strange JE, Gislason G, Mcgettigan P, Holt A ( 2024 ) . Temporal trend of first-line drug choice and treatment continuity for hypertension among citizens 75 years or over - a register-based, cohort study . International Journal of Cardiology vol. 408 ,

Holt A, Strange JE, Rasmussen PV, Nouhravesh N, Nielsen SK, Sindet-Pedersen C, Fosbøl EL, Køber L et al. ( 2024 ) . Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults . Journal of the American College of Cardiology vol. 83 , ( 19 ) 1870 - 1882 .

Brhlikova P, Mehta A, McGettigan P, Pollock AM, Roderick P, Farooqui HH ( 2024 ) . Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics . Journal of Pharmaceutical Policy and Practice vol. 16 , ( 1 )

Holt A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, Schjerning A-M, Vibe Rasmussen P, Torp-Pedersen C, Gislason GH et al. ( 2024 ) . Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study . European Heart Journal vol. 45 , ( 6 ) 475 - 484 .

Holt A, Strange JE, Rasmussen PV, Nouhravesh N, Nielsen SK, Sindet C, Fosboel EL, Koeber L et al. ( 2023 ) . Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines . European Heart Journal vol. 44 , ( Supplement_2 )

McGettigan P, Ferner RE ( 2023 ) . The prescribing safety assessment: Protecting patients from poor prescribing . Medical Teacher vol. 45 , ( 11 ) 1304 - 1305 .

Holt A, Strange JE, Nouhravesh N, Nielsen SK, Malik ME, Schjerning A-M, Køber L, Torp-Pedersen C et al. ( 2023 ) . Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus . Journal of the American College of Cardiology vol. 81 , ( 15 ) 1459 - 1470 .

McGettigan P, Cooper IC, Martin JH, Schjerning A-M, Ferner RE ( 2022 ) . Electrocardiogaffe . The BMJ vol. 379 ,

Holt A, Strange JE, Rasmussen PV, Blanche P, Nouhravesh N, Jensen MH, Schjerning AM, Schou M et al. ( 2022 ) . Cardiovascular risk following cannabinoid treatment for patients with chronic pain . European Heart Journal vol. 43 , ( Supplement_2 )

Holt A, Strange JE, Rasmussen PV, Blanche P, Nouhravesh N, Jensen MH, Schjerning AM, Schou M et al. ( 2022 ) . Risk of heart failure following short-term non-steroidal anti-inflammatory drug use in patients with type 2 diabetes mellitus . European Heart Journal vol. 43 , ( Supplement_2 )

Mehta A, Brhlikova P, McGettigan P, Pollock AM, Roderick P, Farooqui HH ( 2022 ) . Systemic antibiotic sales and WHO recommendations, India . Bulletin of the World Health Organization vol. 100 , ( 10 ) 610 - 619 .

Holt A, Strange JE, Nouhravesh N, McGettigan P, Lamberts M ( 2022 ) . The Reply . The American Journal of Medicine vol. 135 , ( 10 ) e407 - e408 .

McGettigan P, Morales DR, Moreno‐Martos D, Matin N ( 2022 ) . Changing co‐morbidity and increasing deprivation among people living with HIV: UK population‐based cross‐sectional study . HIV Medicine vol. 24 , ( 3 ) 311 - 324 .

Adeyeye E, Maniero C, Magavern EF, Ferner RE, McGettigan P ( 2022 ) . Prescribing direct‐acting oral anticoagulants – Mind the evidence gap . British Journal of Clinical Pharmacology vol. 88 , ( 11 ) 4724 - 4731 .

McGettigan P, Ferner R ( 2022 ) . We need reliable evidence to guide treatment choices for the many, not the few . The BMJ vol. 377 ,

Morales DR, Moreno-Martos D, Matin N, McGettigan P ( 2022 ) . Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysis . EClinicalMedicine vol. 47 ,

Holt A, Blanche P, Jensen AKG, Nouhravesh N, Rajan D, Jensen MH, El-Sheikh M, Schjerning A-M et al. ( 2022 ) . Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study . Annals of Internal Medicine vol. 175 , ( 6 ) 774 - 782 .

Holt A, Strange JE, Rasmussen PV, Blanche P, Nouhravesh N, Jensen MH, Schjerning A-M, Schou M et al. ( 2021 ) . Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran . The American Journal of Medicine vol. 135 , ( 5 ) 595 - 602.e5 .

Holt A, Blanche P, Zareini B, Rasmussen PV, Strange JE, Rajan D, Jensen MH, El-Sheikh M et al. ( 2021 ) . Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants . European Heart Journal vol. 42 , ( Supplement_1 )

Holt A, Blanche P, Jensen AKG, Nouhravesh N, Rajan D, Jensen MH, El-Sheikh M, Schjerning AM et al. ( 2021 ) . Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates . European Heart Journal vol. 42 , ( Supplement_1 )

Holt A, Blanche P, Zareini B, Rasmussen PV, Strange JE, Rajan D, Jensen MH, El-Sheikh M et al. ( 2021 ) . Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants . Heart vol. 108 , ( 8 ) 626 - 632 .

Jonker CJ, de Vries ST, van den Berg HM, McGettigan P, Hoes AW, Mol PGM ( 2021 ) . Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders . Drug Safety vol. 44 , ( 8 ) 853 - 861 .

Holt A, Blanche P, McGettigan P, Lamberts M ( 2021 ) . Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis . European Heart Journal vol. 43 , ( 8 ) 836 - 838 .

Holt A, Blanche P, Zareini B, Rajan D, El-Sheikh M, Schjerning A-M, Schou M, Torp-Pedersen C et al. ( 2021 ) . Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study . European Heart Journal vol. 42 , ( 9 ) 907 - 914 .

Awe E, McGettigan P, Sevcikova P ( 2021 ) . Surrogates in trials supporting European marketing authorisations of medicines for amyloidosis, cystic fibrosis, hepatitis C and idiopathic pulmonary fibrosis . BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . vol. 87 , 1596 - 1596 .

Hodges G, Pallisgaard J, Olsen A-MS, McGettigan P, Andersen M, Krogager M, Kragholm K, Køber L et al. ( 2020 ) . Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study . BMJ Open vol. 10 , ( 12 )

Holt A, Zareini B, Rajan D, Schou M, Gislason GH, Schjerning AM, McGettigan P, Blanche P et al. ( 2020 ) . Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era – a Danish, nationwide, and registry-based cohort study . European Heart Journal vol. 41 , ( Supplement_2 )

Lovegrove E, Robson J, McGettigan P ( 2020 ) . Pregnancy protection and pregnancies in women prescribed ACE inhibitors or ARBs: a cross-sectional study in primary care . British Journal of General Practice vol. 70 , ( 700 ) e778 - e784 .

Robson J, Moss N, McGettigan P, Beardsley SJ, Lovegrove E, Dezateux C ( 2020 ) . Editorials: First do no harm: Valproate and medicines safety in pregnancy . British Journal of General Practice vol. 70 , ( 699 ) 477 - 478 .

McGettigan P, Ferner RE ( 2020 ) . Painful perianal ulcers with nicorandil . The BMJ vol. 370 ,

Schjerning A-M, McGettigan P, Gislason GH ( 2020 ) . Reply to ‘Aspirin as a painkiller in patients with a high cardiovascular risk profile’ . Nature Reviews Cardiology vol. 17 , ( 9 ) 609 - 610 .

Schjerning A-M, McGettigan P, Gislason G ( 2020 ) . Cardiovascular effects and safety of (non-aspirin) NSAIDs . Nature Reviews Cardiology vol. 17 , ( 9 ) 574 - 584 .

Ferner R, McGettigan P ( 2020 ) . The patient who reports a drug allergy . The BMJ vol. 368 ,

Lovegrove E, Robson J, McGettigan P ( 2020 ) . Pregnancy protection and pregnancies in women prescribed angiotensin-converting enzyme inhibitors/angiotensin receptor blockers . BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . vol. 86 , 1194 - 1194 .

Rashid F, Suresan S, McGettigan P ( 2020 ) . Prescribing a single inhaler type: Audit of inhaler prescribing in two London general practices . BRITISH JOURNAL OF PHARMACOLOGY . vol. 177 , 2600 - 2600 .

Schjerning Olsen A-M, Mcgettigan P, Gerds TA, Fosbøl EL, Olesen JB, Sindet-Pedersen C, Staerk L, Hansen ML et al. ( 2019 ) . Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study . European Heart Journal - Cardiovascular Pharmacotherapy

McGettigan P, Olmo CA, Plueschke K, Castillon M, Zondag D, Bahri P, Kurz X, Mol PGM ( 2019 ) . Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments” . Drug Safety vol. 42 , ( 12 ) 1517 - 1518 .

Bruce CS, Brhlikova P, Heath J, McGettigan P ( 2019 ) . The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018 . PLOS Medicine vol. 16 , ( 9 )

McGettigan P, Alonso Olmo C, Plueschke K, Castillon M, Nogueras Zondag D, Bahri P, Kurz X, Mol PGM ( 2019 ) . Patient Registries: An Underused Resource for Medicines Evaluation . Drug Safety vol. 42 , ( 11 ) 1343 - 1351 .

Morales D, Pacurariu A, Slattery J, Pinheiro L, McGettigan P, Kurz X ( 2019 ) . Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy . JAMA Neurology vol. 76 , ( 7 ) 827 - 833 .

Olmo CA, McGettigan P, Kurz X ( 2019 ) . Barriers and Opportunities for Use of Patient Registries in Medicines Regulation . Clinical Pharmacology and Therapeutics vol. 106 , ( 1 ) 39 - 42 .

( 2019 ) . Correction: Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation . BMJ Open vol. 8 , ( 11 )

Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X ( 2019 ) . Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study . Clinical Drug Investigation vol. 39 , ( 2 ) 215 - 215 .

Barcella CA, Lamberts M, McGettigan P, Fosbøl EL, Lindhardsen J, Torp‐Pedersen C, Gislason GH, Olsen AS ( 2019 ) . Differences in cardiovascular safety with non‐steroidal anti‐inflammatory drug therapy—A nationwide study in patients with osteoarthritis . Basic & Clinical Pharmacology & Toxicology vol. 124 , ( 5 ) 629 - 641 .

McGettigan P, Olmo CA, Plueschke K, Castillon M, Zondag D, Bahri P, Kurz X, Mol P ( 2019 ) . Improving the use of patient registries in regulatory evaluations . BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . vol. 85 , 1652 - 1652 .

Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X ( 2018 ) . Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study . Clinical Drug Investigation vol. 39 , ( 2 ) 205 - 213 .

Ferner RE, McGettigan P ( 2018 ) . Adverse drug reactions . The BMJ vol. 363 ,

Pacurariu A, Plueschke K, McGettigan P, Morales DR, Slattery J, Vogl D, Goedecke T, Kurz X et al. ( 2018 ) . Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation . BMJ Open vol. 8 , ( 9 )

Plueschke K, McGettigan P, Pacurariu A, Kurz X, Cave A ( 2018 ) . EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making . BMJ Open vol. 8 , ( 6 )

McGettigan P, Roderick P, Kadam A, Pollock A ( 2018 ) . Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India . British Journal of Clinical Pharmacology vol. 85 , ( 1 ) 59 - 70 .

Morales DR, Slattery J, Pacurariu A, McGettigan P, Kurz X ( 2018 ) . Association between systemic fluoroquinolone exposure and tendon rupture: Population-based nested case-control study . PHARMACOEPIDEMIOLOGY AND DRUG SAFETY . vol. 27 , 339 - 339 .

MCGETTIGAN P, Roderick P, Kadam A, Pollock A ( 2017 ) . Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship . The Lancet Global Health vol. 5 , ( 11 ) e1075 - e1076 .

McGettigan P, Olsen A-MS ( 2017 ) . NSAIDs for high-risk patients: none, celecoxib, or naproxen? . The Lancet vol. 389 , ( 10087 ) 2351 - 2352 .

McGettigan P, Ferner RE ( 2017 ) . PCSK9 inhibitors for hypercholesterolaemia . The BMJ vol. 356 ,

Plueschke K, Kurz X, Cave A, McGettigan P, Pacurariu A ( 2017 ) . Supporting Pharmacovigilance by Landscaping EU-funded Real World Data . DRUG SAFETY . vol. 40 , 949 - 949 .

McGettigan P, McKendree J ( 2016 ) . Presence of Medical Students and Length of Stay in the Emergency Department . JAMA vol. 315 , ( 18 ) 2019 - 2019 .

Matin N, Trivedi B, Holyoak H, McGettigan P ( 2016 ) . Combined HIV/cardiovascular clinic: review of patient cohort and analysis of outcomes . HIV MEDICINE . vol. 17 , 47 - 47 .

McGettigan P, McKendree J ( 2015 ) . Interprofessional training for final year healthcare students: a mixed methods evaluation of the impact on ward staff and students of a two-week placement and of factors affecting sustainability . BMC Medical Education vol. 15 , ( 1 )

Schjerning Olsen A-M, Lindhardsen J, Gislason GH, McGettigan P, Hlatky MA, Fosbøl E, Køber L, Torp-Pedersen C et al. ( 2015 ) . Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study . The BMJ vol. 351 ,

McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock AM ( 2015 ) . Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs . PLOS Medicine vol. 12 , ( 5 )

Steele S, Freitag A, McGettigan P, Giovannoni G, Pollock AM ( 2015 ) . A guide to private prescribing . Prescriber vol. 26 , ( 6 ) 19 - 23 .

Olsen A-MS, Gislason GH, McGettigan P, Fosbøl E, Sørensen R, Hansen ML, Køber L, Torp-Pedersen C et al. ( 2015 ) . Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial Infarction . JAMA vol. 313 , ( 8 ) 805 - 814 .

Olsen AMS, Lindhardsen J, Gislason G, McGettigan P, Hlatky M, Koeber L, Torp-Pedersen C, Lamberts M ( 2015 ) . Impact of PPI treatment on gastrointestinal bleeding associated with NSAID use among post-myocardial infarction patients on antithrombotic therapy - A nationwide study . EUROPEAN HEART JOURNAL . vol. 36 , 1152 - 1152 .

O’Doherty AM, McGettigan PA ( 2014 ) . Epigenetic processes in the male germline . Reproduction Fertility and Development vol. 27 , ( 5 ) 725 - 738 .

Roderick P, Mahajan R, McGettigan P, Pollock AM, Jeffery R ( 2014 ) . Need for a new drugs bill . Economic and Political Weekly vol. 49 , ( 33 ) 15 - 19 .

Conroy J, McGettigan PA, McCreary D, Shah N, Collins K, Parry‐Fielder B, Moran M, Hanrahan D et al. ( 2014 ) . Towards the identification of a genetic basis for Landau‐Kleffner syndrome . Epilepsia vol. 55 , ( 6 ) 858 - 865 .

Casey JP, McGettigan PA, Healy F, Hogg C, Reynolds A, Kennedy BN, Ennis S, Slattery D et al. ( 2014 ) . Unexpected genetic heterogeneity for primary ciliary dyskinesia in the Irish Traveller population . European Journal of Human Genetics vol. 23 , ( 2 ) 210 - 217 .

Forde N, McGettigan PA, Mehta JP, O'Hara L, Mamo S, Bazer FW, Spencer TE, Lonergan P ( 2014 ) . Proteomic analysis of uterine fluid during the pre-implantation period of pregnancy in cattle . Reproduction vol. 147 , ( 5 ) 575 - 587 .

McGettigan P, Pollock A, Herxheimer A ( 2014 ) . Department of Health's misguided alert recommending neuraminidase inhibitors for flu . BMJ vol. 348 ,

Roderick P, Mahajan R, McGettigan P, Pollock AM ( 2014 ) . India should introduce a new Drugs Act . Lancet vol. 383 , ( 9913 ) 203 - 206 .

McGettigan P, Pollock A, Herxheimer A ( 2014 ) . OSELTAMIVIR AND ZANAMIVIR FOR FLU Department of Health's misguided alert recommending neuraminidase inhibitors for flu . BMJ-BRITISH MEDICAL JOURNAL vol. 348 , Article ARTN g1594 ,

Herxheimer A, McGettigan P ( 2013 ) . Problems of polypharmacy . BMJ vol. 347 ,

Forde N, Mehta JP, McGettigan PA, Mamo S, Bazer FW, Spencer TE, Lonergan P ( 2013 ) . Alterations in expression of endometrial genes coding for proteins secreted into the uterine lumen during conceptus elongation in cattle . BMC Genomics vol. 14 , ( 1 )

McGettigan P, McKendree J, Reed N, Holborow S, Walsh CD, Mace T ( 2013 ) . Identifying attributes required by Foundation Year 1 doctors in multidisciplinary teams: a tool for performance evaluation . BMJ Qual Saf vol. 22 , ( 3 ) 225 - 232 .

McGettigan PA ( 2013 ) . Transcriptomics in the RNA-seq era . Current Opinion in Chemical Biology vol. 17 , ( 1 ) 4 - 11 .

McGettigan P, Henry D ( 2013 ) . Use of NSAIDs with Increased Risk of Cardiovascular Events in Low and Middle Income Countries . PHARMACOEPIDEMIOLOGY AND DRUG SAFETY vol. 22 , 423 - 423 .

McGettigan P, Henry D ( 2013 ) . Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries . PLoS Med vol. 10 , ( 2 )

Hundley V, Avan B, Sullivan C, Graham W ( 2012 ) . Should oral misoprostol be used to prevent postpartum haemorrhage in home‐birth settings in low‐resource countries? A systematic review of the evidence . BJOG An International Journal of Obstetrics & Gynaecology vol. 120 , ( 3 ) 277 - 287 .

Pluta K, McGettigan PA, Reid CJ, Browne JA, Irwin JA, Tharmalingam T, Corfield A, Baird A et al. ( 2012 ) . Molecular aspects of mucin biosynthesis and mucus formation in the bovine cervix during the periestrous period . Physiological Genomics vol. 44 , ( 24 ) 1165 - 1178 .

Mullen MP, Creevey CJ, Berry DP, McCabe MS, Magee DA, Howard DJ, Killeen AP, Park SD et al. ( 2012 ) . Polymorphism discovery and allele frequency estimation using high-throughput DNA sequencing of target-enriched pooled DNA samples . BMC Genomics vol. 13 , ( 1 )

McGettigan P, Lincz LF, Attia J, McElduff P, Bissett L, Peel R, Stokes B, Hancock S et al. ( 2011 ) . The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene . BRIT J CLIN PHARMACO vol. 72 , ( 4 ) 707 - 714 .

McGettigan P, Henry D ( 2011 ) . Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies . PLoS Med vol. 8 , ( 9 )

McGettigan P, Henry D ( 2011 ) . Cardiovascular Events after Prescription of NSAIDs - Updated Systematic Review of Pharmaco-Epidemiological Studies . PHARMACOEPIDEM DR S vol. 20 , S324 - S325 .

Waring WS, McGettigan P ( 2011 ) . Clinical toxicology and drug regulation: A United Kingdom perspective . CLIN TOXICOL vol. 49 , ( 6 ) 452 - 456 .

McGettigan P, Henry D ( 2011 ) . EVALUATION OF CARDIOVASCULAR RISK WITH NSAIDS: LIMITATIONS ARISING FROM INCONSISTENT REPORTING IN PHARMACOEPIDEMIOLOGICAL STUDIE . BASIC CLIN PHARMACOL vol. 109 , 139 - 139 .

McGettigan P, Henry D ( 2011 ) . PHARMACOEPIDEMIOLOGICAL STUDIES ADVANCE THE INFORMATION FROM RANDOMIZED TRIALS INVESTIGATING NSAID ASSOCIATED CARDIOVASCULAR RISK . BASIC CLIN PHARMACOL vol. 109 , 25 - 25 .

McGivney BA, McGettigan PA, Browne JA, Evans AC, Fonseca RG, Loftus BJ, Lohan A, MacHugh DE et al. ( 2010 ) . Characterization of the equine skeletal muscle transcriptome identifies novel functional responses to exercise training . BMC Genomics vol. 11 , ( 1 )

Edwards CJ, Magee DA, Park SDE, McGettigan PA, Lohan AJ, Murphy A, Finlay EK, Shapiro B et al. ( 2010 ) . A Complete Mitochondrial Genome Sequence from a Mesolithic Wild Aurochs (Bos primigenius) . PLOS ONE vol. 5 , ( 2 )

O'Sullivan NC, Croydon L, McGettigan PA, Pickering M, Murphy KJ ( 2009 ) . Hippocampal region-specific regulation of NF-κB may contribute to learning-associated synaptic reorganisation . Brain Research Bulletin vol. 81 , ( 4-5 ) 385 - 390 .

Henry D, Lincz L, Attia J, McElduff P, Bisset L, Peel R, Hancock S, Henderson K et al. ( 2009 ) . POLYMORPHISMS IN TWO REGIONS OF THE CYCLO-OXYGENASE-2 GENE ASSOCIATED WITH VARIATION IN RISK OF CORONARY THROMBOSIS WITH CYCLO-OXYGENASE-2 INHIBITORS . BASIC CLIN PHARMACOL vol. 105 , 39 - 39 .

Henry D, Lincz L, Attia J, McElduff P, Bisset L, Peel R, Hancock S, Henderson K et al. ( 2009 ) . Polymorphisms in Two Regions of the Cyclo-Oxygenase-2 Gene Associated with Variation in Risk of Coronary Thrombosis with Cyclo-Oxygenase-2 Inhibitors . PHARMACOEPIDEM DR S vol. 18 , S116 - S116 .

McGettigan P, Dakkak E, Morris I ( 2009 ) . TRAINING MEDICAL STUDENTS TO PRESCRIBE: HYMS' EVOLVING TEACHING MODEL . BASIC CLIN PHARMACOL vol. 105 , 42 - 42 .

McGettigan P, Peel R, Stokes B, Henderson K, Whitaker D, Henry D ( 2009 ) . WHAT DID 'SAFE' MEAN TO PRESCRIBERS OF SELECTIVE COX-2 INHIBITORS? . BASIC CLIN PHARMACOL vol. 105 , 90 - 90 .

Ringland C, Mant A, McGettigan P, Mitchell P, Kelman C, Buckley N, Pearson SA ( 2008 ) . Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data . BRIT J CLIN PHARMACO vol. 66 , ( 5 ) 682 - 688 .

McGettigan P, Han P, Jones L, Whitaker D, Henry D ( 2008 ) . Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases . BRIT J CLIN PHARMACO vol. 65 , ( 6 ) 927 - 934 .

Moxey AJ, Adams CA, Stokes B, McGettigan P ( 2007 ) . Describing treatment options to patients with cancer: The influence of information framing . PSYCHO-ONCOL vol. 16 , ( 9 ) S168 - S169 .

McGettigan P, Henry D ( 2007 ) . COX-2, NSAIDs, and cardiovascular risk . Current Cardiovascular Risk Reports vol. 1 , ( 4 ) 296 - 302 .

Henry DA, McGettigan P, Tonkin A, Hennessy S ( 2007 ) . Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies . Pharmacoepidemiology , Wiley

Henry D, McGettigan P ( 2007 ) . Cyclooxygenase inhibitors and cardiovascular risk - Reply . JAMA-J AM MED ASSOC vol. 297 , ( 6 ) 587 - 588 .

Henry D, McGettigan P ( 2007 ) . Selective COX-2 inhibitors: A promise unfulfilled? . GASTROENTEROLOGY vol. 132 , ( 2 ) 790 - 794 .

Attia J, Thakkinstian A, Wang Y, Lincz L, Parsons M, Sturm J, McGettigan P, Scott R et al. ( 2007 ) . The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis . J Stroke Cerebrovasc Dis vol. 16 , ( 4 ) 173 - 179 .

O’Sullivan NC, McGettigan PA, Sheridan GK, Pickering M, Conboy L, O’Connor JJ, Moynagh PN, Higgins DG et al. ( 2006 ) . Temporal change in gene expression in the rat dentate gyrus following passive avoidance learning . Journal of Neurochemistry vol. 101 , ( 4 ) 1085 - 1098 .

Jeffery IB, Madden SF, McGettigan PA, Perrière G, Culhane AC, Higgins DG ( 2006 ) . Integrating transcription factor binding site information with gene expression datasets . Bioinformatics vol. 23 , ( 3 ) 298 - 305 .

Doust J, McGettigan P ( 2006 ) . Interpreting clinical trials . Australian Doctor ( 13/OCT. ) 29 - 35 .

McGettigan P, Henry D ( 2006 ) . Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase . JAMA-J AM MED ASSOC vol. 296 , ( 13 ) 1633 - 1644 .

Moxey AJ, Adams CA, McGettigan P ( 2006 ) . Making treatment decisions for cancer: What do patients consider? . PSYCHO-ONCOL vol. 15 , ( 2 ) S338 - S339 .

McGettigan P, Han P, Henry D ( 2006 ) . Cyclooxygenase-2 inhibitors and coronary occlusion - exploring dose-response relationships . BRIT J CLIN PHARMACO vol. 62 , ( 3 ) 358 - 365 .

McGettigan P, Feely J ( 2006 ) . Adverse drug reaction reporting: Opinions and attitudes of medical practitioners in Ireland . Pharmacoepidemiology and Drug Safety vol. 4 , ( 6 ) 355 - 358 .

Robertson J, McGettigan P ( 2006 ) . What price research? . Aust Fam Physician vol. 35 , ( 1-2 )

Robertson J, Walkom EJ, McGettigan P ( 2005 ) . Response rates and representativeness: a lottery incentive improves physician survey return rates . PHARMACOEPIDEM DR S vol. 14 , ( 8 ) 571 - 577 .

McGettigan P, Henry D ( 2005 ) . Medical research and the news media . NEW ENGL J MED vol. 352 , ( 8 ) 838 - 838 .

Moxey A, O'Connell D, McGettigan P, Henry D ( 2003 ) . Describing treatment effects to patients - How they are expressed makes a difference . JOURNAL OF GENERAL INTERNAL MEDICINE . vol. 18 , 948 - U8 .

Moxey A, O'Connell D, McGettigan P, Henry D ( 2003 ) . Describing treatment effects to patients . J Gen Intern Med vol. 18 , ( 11 ) 948 - 959 .

Henry D, McGettigan P ( 2003 ) . Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs . INTERNATIONAL JOURNAL OF CLINICAL PRACTICE . 43 - 49 .

Isbister GK, Whyte IM, Downes F, Dawson AH, McGettigan P ( 2003 ) . Concomitant overdosing of other drugs in patients with paracetamol poisoning . BRIT J CLIN PHARMACO vol. 55 , ( 3 ) 325 - 325 .

Isbister GK, McGettigan P, Harris I ( 2003 ) . Hyperbaric oxygen for acute carbon monoxide poisoning . NEW ENGL J MED vol. 348 , ( 6 ) 558 - 558 .

Isbister GK, McGettigan P, Harris I ( 2003 ) . Hyperbaric oxygen for acute carbon monoxide poisoning . N Engl J Med vol. 348 , ( 6 ) 557 - 560 .

McGettigan P, Isbister GK, Whyte IM ( 2003 ) . Adolescent depression . NEW ENGL J MED vol. 348 , ( 5 ) 473 - 473 .

Henry D, McGettigan P ( 2003 ) . Upper gastrointestinal event risk with COX-2 inhibitors depended on known risk factors . ACP J Club vol. 138 , ( 2 )

McGettigan P, Henry DA, Hennessy S ( 2002 ) . Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies . Pharmacoepidemiology , Wiley

Isbister GK, McGettigan P, Dawson A ( 2001 ) . A fatal case of moclobemide-citalopram intoxication . J ANAL TOXICOL vol. 25 , ( 8 ) 716 - 717 .

Moxey A, O'Connell D, McGettigan P, Henry D ( 2001 ) . The effects of information framing on patients' treatment decisions . BMC News and views vol. 1 , ( S3 )

McGettigan P, Golden J, Fryer J, Chan R, Feely J ( 2001 ) . Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message . BRIT J CLIN PHARMACO vol. 51 , ( 2 ) 184 - 189 .

Smith AJ, McGettigan P ( 2000 ) . Quality use of medicines in the community: the Australian experience . BRIT J CLIN PHARMACO vol. 50 , ( 6 ) 515 - 519 .

McGettigan P, Kelly A, Carvahlo M, Feely J ( 2000 ) . Anti-depressants in primary care: Analysis of treatment discontinuations . PHARMACOEPIDEM DR S vol. 9 , ( 6 ) 521 - 528 .

McGettigan P, Henry D ( 2000 ) . Current problems with non-specific COX inhibitors . CURR PHARM DESIGN vol. 6 , ( 17 ) 1693 - 1724 .

McGettigan P ( 2000 ) . COX-2 inhibitors. What is their place? . Aust Fam Physician vol. 29 , ( 9 ) 847 - 852 .

Henry D, McGettigan P ( 2000 ) . Celecoxib was similar to naproxen for rheumatoid arthritis with fewer endoscopic ulcers . Annals of Internal Medicine vol. 132 , ( 3 )

Henry D, McGettigan P ( 2000 ) . Rofecoxib caused fewer endoscopic gastroduodenal ulcers than ibuprofen in osteoarthritis . Annals of Internal Medicine vol. 132 , ( 3 )

Feely T, McGettigan P, Kelly A ( 2000 ) . Growth in use of statins after trials is not targeted to most appropriate patients . CLIN PHARMACOL THER vol. 67 , ( 4 ) 438 - 441 .

McGettigan P, Platona A, Henry DA ( 2000 ) . Renal and cardiovascular toxicity of non-steroidal anti-inflammatory drugs . Inflammopharmacology vol. 8 , ( 1 ) 1 - 18 .

McGettigan P, Sly K, O'Connell D, Hill S, Henry D ( 1999 ) . The effects of information framing on the practices of physicians . J GEN INTERN MED vol. 14 , ( 10 ) 633 - 642 .

Henry D, McGettigan P ( 1999 ) . Cardiac and renal failure due to NSAIDs: a review of the epidemiological literature . Inflammopharmacology vol. 7 , ( 3 ) 311 - 338 .

McGettigan P, Henry D, Page J ( 1998 ) . Adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal tract and kidney: relationship to cyclooxygenase-2 selectivity . CLINICAL SIGNIFICANCE AND POTENTIAL OF SELECTIVE COX-2 INHIBITORS . Editors: Vane, JR, Botting, RM , 149 - 160 .

( 1998 ) . National Scientific Medical meeting. 27-28 March 1998. Abstracts . Irish Journal of Medical Science . vol. 167 Suppl 5 , 1 - 46 .

Feely J, Golden J, Chan R, McGettigan P ( 1997 ) . Who is kidding who? Sources of influence when prescribing new drugs . Clinical Pharmacology and Therapeutics vol. 61 , ( 2 )

Belton KJ, Gram LF, Royer RJ, Feely J, McGettigan P, Velo GP, Conforti A, Leone R et al. ( 1997 ) . Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union . EUR J CLIN PHARMACOL vol. 52 , ( 6 ) 423 - 427 .

McGettigan P, Mooney EE, Sinnott M, Sweeney EC, Feely J ( 1997 ) . Sudden death in Whipple's disease . POSTGRAD MED J vol. 73 , ( 862 ) 509 - 511 .

McGettigan P, Golden J, Conroy RM, Arthur N, Feely J ( 1997 ) . Reporting of adverse drug reactions by hospital doctors and the response to intervention . BRIT J CLIN PHARMACO vol. 44 , ( 1 ) 98 - 100 .

McGettigan P, McManus J, OShea B, Chan R, Feely J ( 1997 ) . Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: Prescribers' concerns . IRISH MED J vol. 90 , ( 4 ) 146 - 147 .

Hemeryck L, McGettigan P, Feely J ( 1997 ) . Hospital antibiotic prescribing and feedback . BRIT J CLIN PHARMACO vol. 43 , ( 4 ) 449 - 450 .

Feely J, Golden J, Chan R, McGettigan P ( 1997 ) . Who is kidding who? Sources of influence when prescribing new drugs . CLIN PHARMACOL THER vol. 61 , ( 2 ) PII80 - PII80 .

Mcgettigan P, Golden J, Arthur N, Feely J ( 1996 ) . Adverse drug reaction reporting by hospital doctors: Knowledge, use of the system and response to intervention . British Journal of Clinical Pharmacology vol. 41 , ( 5 )

Mcgettigan P, Feely J ( 1996 ) . Limited impact on reinstatement of medicines to a national limited list . British Journal of Clinical Pharmacology vol. 41 , ( 5 )

Mcgettigan P, Golden J, Chan R, Feely J ( 1996 ) . Sources of information used by hospital doctors when prescribing new drugs . British Journal of Clinical Pharmacology vol. 41 , ( 5 )

Wen Y, Killalea S, McGettigan P, Feely J ( 1996 ) . Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients . IRISH J MED SCI vol. 165 , ( 3 ) 210 - 212 .

Neelamakam PK, Brazil E, Attwood S, Traynor O, Yaqoob J, Khan MI, O’Toole D, Noonan N et al. ( 1995 ) . Irish Society of Gastroenterology . Irish Journal of Medical Science vol. 164 , ( 2 ) 175 - 190 .

Norris S, Collins C, Hegarty J, O’Farrelly C, Carton J, Madrigal L, O’Donoghue DP, O’Farrelly C et al. ( 1995 ) . National scientific medical meeting 1995 abstracts . Irish Journal of Medical Science vol. 164 , ( Suppl 14 ) 1 - 53 .

LEE TC, ODRISCOLL KJ, MCGETTIGAN P, MORAES D, RAMPHALL S, OBRIEN M ( 1988 ) . THE SITE OF THE TENDINOUS INTERRUPTION IN SEMITENDINOSUS IN MAN . J ANAT vol. 157 , 229 - 231 .

Walsh C, Rooney BP, Coakley JB, O’Driscoll KJ, Lee TC, McGettigan P, Moreas D, Rampal S et al. ( 1987 ) . Royal Academy of Medicine in Ireland Section of Biological Sciences Proceedings of Winter Meeting held on Monday, 5th January, 1987 . Irish Journal of Medical Science vol. 156 , ( 10 ) 292 - 305 .